Approval · Notice of Compliance 3823 · 1997
FORADIL: Notice of Compliance 3823
Issued March 6, 1997
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3823
- Date
- March 6, 1997
- Company
- Novartis Pharmaceuticals Canada Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Bronchodilator
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FORADIL | 02230898 | Cancelled Post Market |
Medicinal ingredients
- FORMOTEROL FUMARATE 12 MCG per CAP